You are here

MerLion scores a first for S'pore with FDA approval of its ear infection drug


BIOPHARMACEUTICAL company MerLion Pharmaceuticals is the first homegrown company to have its new novel drug approved by the United States Food and Drug Administration (FDA), paving the way for it to be commercially available to treat ear infections.

This follows Phase 3...

Market voices on: